CRISPR Therapeutics AG

Stocks

Real-time Estimate Cboe BZX Other stock markets 07:49:11 21/07/2026 pm IST			5-day change	1st Jan Change
48.48 ^USD	+3.17%		-4.99%	-8.58%

30/06	CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell Small Cap Comp Growth Benchmark	CI
30/06	CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell 2500 Growth Benchmark	CI

Published on 06/10/2026 at 02:21 am IST

S&P Capital IQ

Presenter Speech
Salveen Richter (Analysts)

Good afternoon. Thank you, everyone, for joining us. We're really pleased to have with us CRISPR Therapeutics. And with me, I have Raju Prasad, CFO.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

30/06	CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell Small Cap Comp Growth Benchmark	CI
30/06	CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell 2500 Growth Benchmark	CI
29/06	CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell 2000 Growth Benchmark	CI
29/06	CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell 3000E Growth Benchmark	CI
29/06	CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell 3000 Growth Benchmark	CI
10/06	CRISPR Therapeutics AG Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 02:40 PM
05/06	CRISPR Therapeutics AG Presents at 46th Annual William Blair Growth Stock Conference, Jun-03-2026 04:40 PM
04/06	CRISPR Therapeutics AG Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 09:55 AM
13/05	CRISPR Therapeutics AG Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 01:40 PM
05/05	Earnings Flash (CRSP) CRISPR Therapeutics AG Reports Q1 Revenue $1.5M, vs. FactSet Est of $6.1M	MT
05/05	CRISPR Therapeutics AG Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
14/04	CRISPR Therapeutics AG Presents at 25th Annual Needham Virtual Healthcare Conference, Apr-13-2026 02:15 PM
25/03	Crispr Therapeutics Insider Sold Shares Worth $468,736, According to a Recent SEC Filing	MT
11/03	Crispr Therapeutics Prices $550 Million Convertible Notes Offering	MT
11/03	CRISPR Therapeutics prices upsized convertible senior notes offering	RE